Back to Search
NEAL SHAH, MD
MD
Cardiovascular Disease Physician
NPI: 1063705515IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
A124235(CA)
Education
UNIVERSITY OF CALIFORNIA, GEFFEN SCHOOL OF MEDICINE
Class of 2011
Research & Publications (20)
Advanced CML: therapeutic options for patients in accelerated and blast phases.
PMID 18397679·J Natl Compr Canc Netw·2008
6-review
Transient potent BCR-ABL inhibition is sufficient to commit chronic myeloid leukemia cells irreversibly to apoptosis.
PMID 19061839·Cancer Cell·2008
8-other
Intermittent target inhibition with dasatinib 100 mg once daily preserves efficacy and improves tolerability in imatinib-resistant and -intolerant chronic-phase chronic myeloid leukemia.
PMID 18541900·J Clin Oncol·2008
3-trial
Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency.
PMID 17710227·J Clin Invest·2007
7-preclinical
Design and evaluation of novel nonsteroidal dissociating glucocorticoid receptor ligands.
PMID 15380227·Bioorg Med Chem Lett·2004
8-other
The effect of recombinant human erythropoietin on the development of retinopathy of prematurity.
PMID 19565433·Am J Perinatol·2010
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 535 MISSION BAY BLVD S
SAN FRANCISCO, CA 94143 - Phone
- (415) 353-2873
Quick Facts
- NPI
- 1063705515
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 15
- Publications
- 20
Are you this provider?
Claim Your Profile